Showing results (121-130 of 217) with videos related to

Sort By:
Pageof 22
The Lancet. Rheumatology|January 17, 2024
Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, phase 3 trialRichard A Furie, Eric F Morand, Ian N Bruce, et al.
Lupus Science & Medicine|March 29, 2022
Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteriaRonald van Vollenhoven, Anca D Askanase, Andrew S Bomback, et al.
Magnetic Resonance Imaging|October 17, 2022
Imaging biomarkers of lung ventilation in interstitial lung disease from <sup>129</sup>Xe and oxygen enhanced <sup>1</sup>H MRIMarta Tibiletti, James A Eaden, Josephine H Naish, et al.
Journal of Clinical Medicine|October 18, 2018
Drug-Induced Interstitial Lung Disease: A Systematic ReviewSarah Skeoch, Nicholas Weatherley, Andrew J Swift, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 12, 2022
A Randomized, Placebo-Controlled Phase III Extension Trial of the Long-Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus ErythematosusKenneth C Kalunian, Richard Furie, Eric F Morand, et al.
Arthritis and Rheumatism|December 1, 2007
British Isles Lupus Assessment Group 2004 index is valid for assessment of disease activity in systemic lupus erythematosusChee-Seng Yee, Vernon Farewell, David A Isenberg, et al.
Rheumatology (Oxford, England)|February 26, 2010
Numerical scoring for the BILAG-2004 indexChee-Seng Yee, Lynne Cresswell, Vernon Farewell, et al.
Lupus Science & Medicine|May 22, 2024
Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestationsAnca D Askanase, Richard A Furie, Maria Dall'Era, et al.
Rheumatology (Oxford, England)|January 20, 2011
The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patientsChee-Seng Yee, Vernon T Farewell, David A Isenberg, et al.
Annals of the Rheumatic Diseases|July 21, 2010
Variants in linkage disequilibrium with the late cornified envelope gene cluster deletion are associated with susceptibility to psoriatic arthritisJohn Bowes, Edward Flynn, Pauline Ho, et al.
Pageof 22